Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 436

1.

Low-level blast exposure disrupts gliovascular and neurovascular connections and induces a chronic vascular pathology in rat brain.

Gama Sosa MA, De Gasperi R, Perez Garcia GS, Perez GM, Searcy C, Vargas D, Spencer A, Janssen PL, Tschiffely AE, McCarron RM, Ache B, Manoharan R, Janssen WG, Tappan SJ, Hanson RW, Gandy S, Hof PR, Ahlers ST, Elder GA.

Acta Neuropathol Commun. 2019 Jan 9;7(1):6. doi: 10.1186/s40478-018-0647-5.

2.

Frequency, Timing, and Types of Medication Ordering Errors Made by Residents in the Electronic Medical Records Era.

Garber A, Nowacki AS, Chaitoff A, Brateanu A, Colbert CY, Bauer SR, Arora Z, Mehdi A, Lam S, Spencer A, Rothberg MB.

South Med J. 2019 Jan;112(1):25-31. doi: 10.14423/SMJ.0000000000000923.

PMID:
30608627
3.

Do time trade-off values fully capture attitudes that are relevant to health-related choices?

Spencer A, Tomeny E, Mujica-Mota RE, Robinson A, Covey J, Pinto-Prades JL.

Eur J Health Econ. 2018 Dec 31. doi: 10.1007/s10198-018-1017-8. [Epub ahead of print]

PMID:
30596209
4.

Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis.

Dane A, Spencer A, Rosenkranz G, Lipkovich I, Parke T; PSI/EFSPI Working Group on Subgroup Analysis.

Pharm Stat. 2018 Dec 27. doi: 10.1002/pst.1919. [Epub ahead of print]

PMID:
30592133
5.

Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Surman C, Ceranoglu A, Vaudreuil C, Albright B, Uchida M, Yule A, Spencer A, Boland H, Grossman R, Rhodewalt L, Fitzgerald M, Biederman J.

J Clin Psychopharmacol. 2019 Jan/Feb;39(1):28-38. doi: 10.1097/JCP.0000000000000990.

PMID:
30566416
6.

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.

Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group.

Lancet. 2018 Dec 10. pii: S0140-6736(18)33003-4. doi: 10.1016/S0140-6736(18)33003-4. [Epub ahead of print]

PMID:
30545780
7.

Older adults exhibit variable responses in stepping behaviour following unexpected forward perturbations during gait initiation.

Shulman D, Spencer A, Ann Vallis L.

Hum Mov Sci. 2018 Dec 1;63:120-128. doi: 10.1016/j.humov.2018.11.008. [Epub ahead of print]

PMID:
30513458
8.

Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myeloma.

Kumar SK, Grzasko N, Delimpasi S, Jedrzejczak WW, Grosicki S, Kyrtsonis MC, Spencer A, Gupta N, Teng Z, Byrne C, Labotka R, Dimopoulos MA.

Br J Haematol. 2018 Nov 20. doi: 10.1111/bjh.15679. [Epub ahead of print]

PMID:
30460684
9.

Evaluating Urban Taeniasis as a Threat to Cysticercosis Elimination in Northern Peru.

Fernandez L, Gamboa R, Vilchez P, Pray I, Beam M, Garvey B, Spencer A, Atto R, Muro C, Moyano LM, Garcia HH, O'Neal SE, For The Cysticercosis Working Group In Peru.

Am J Trop Med Hyg. 2019 Jan;100(1):140-142. doi: 10.4269/ajtmh.18-0767.

PMID:
30457096
10.

A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis.

Weisel K, Sonneveld P, Spencer A, Beksac M, Rizzo M, Xu Y, Fahrbach K, Gaudig M, Slavcev M, Dearden L, Lam A.

Leuk Lymphoma. 2018 Nov 8:1-12. doi: 10.1080/10428194.2018.1466392. [Epub ahead of print]

PMID:
30407092
11.

A framework to address key issues of neonatal service configuration in England: the NeoNet multimethods study.

Villeneuve E, Landa P, Allen M, Spencer A, Prosser S, Gibson A, Kelsey K, Mujica-Mota R, Manktelow B, Modi N, Thornton S, Pitt M.

Southampton (UK): NIHR Journals Library; 2018 Oct.

12.

Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation.

de Silva HD, Ffrench RA, Korem M, Orlowski E, Curtis DJ, Spencer A, Avery S, Patil S, Morrissey CO.

Clin Transl Immunology. 2018 Oct 5;7(10):e1040. doi: 10.1002/cti2.1040. eCollection 2018.

13.

Therapeutic strategies for enhancing angiogenesis in wound healing.

Veith AP, Henderson K, Spencer A, Sligar AD, Baker AB.

Adv Drug Deliv Rev. 2018 Sep 26. pii: S0169-409X(18)30246-1. doi: 10.1016/j.addr.2018.09.010. [Epub ahead of print] Review.

PMID:
30267742
14.

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR.

Spencer A, Lentzsch S, Weisel K, Avet-Loiseau H, Mark TM, Spicka I, Masszi T, Lauri B, Levin MD, Bosi A, Hungria V, Cavo M, Lee JJ, Nooka AK, Quach H, Lee C, Barreto W, Corradini P, Min CK, Scott EC, Chanan-Khan AA, Horvath N, Capra M, Beksac M, Ovilla R, Jo JC, Shin HJ, Sonneveld P, Soong D, Casneuf T, Chiu C, Amin H, Qi M, Thiyagarajah P, Sasser AK, Schecter JM, Mateos MV.

Haematologica. 2018 Sep 20. pii: haematol.2018.194118. doi: 10.3324/haematol.2018.194118. [Epub ahead of print]

15.

Singing for people with aphasia (SPA): a protocol for a pilot randomised controlled trial of a group singing intervention to improve well-being.

Tarrant M, Carter M, Dean SG, Taylor RS, Warren FC, Spencer A, Adamson J, Landa P, Code C, Calitri R.

BMJ Open. 2018 Sep 10;8(9):e025167. doi: 10.1136/bmjopen-2018-025167.

16.

Cost-effectiveness of a domestic violence and abuse training and support programme in primary care in the real world: updated modelling based on an MRC phase IV observational pragmatic implementation study.

Barbosa EC, Verhoef TI, Morris S, Solmi F, Johnson M, Sohal A, El-Shogri F, Dowrick S, Ronalds C, Griffiths C, Eldridge S, Lewis NV, Devine A, Spencer A, Feder G.

BMJ Open. 2018 Aug 29;8(8):e021256. doi: 10.1136/bmjopen-2017-021256.

17.

The Residency Match: Interview Experiences, Postinterview Communication, and Associated Distress.

Berriochoa C, Reddy CA, Dorsey S, Campbell S, Poblete-Lopez C, Schlenk R, Spencer A, Lee J, Eagleton M, Tendulkar RD.

J Grad Med Educ. 2018 Aug;10(4):403-408. doi: 10.4300/JGME-D-17-01020.1.

PMID:
30154970
18.

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis.

Gay F, Jackson G, Rosiñol L, Holstein SA, Moreau P, Spada S, Davies F, Lahuerta JJ, Leleu X, Bringhen S, Evangelista A, Hulin C, Panzani U, Cairns DA, Di Raimondo F, Macro M, Liberati AM, Pawlyn C, Offidani M, Spencer A, Hájek R, Terpos E, Morgan GJ, Bladé J, Sonneveld P, San-Miguel J, McCarthy PL, Ludwig H, Boccadoro M, Mateos MV, Attal M.

JAMA Oncol. 2018 Oct 1;4(10):1389-1397. doi: 10.1001/jamaoncol.2018.2961.

PMID:
30098165
19.

Mining the Plasma Cell Transcriptome for Novel Cell Surface Proteins.

Trezise S, Karnowski A, Fedele PL, Mithraprabhu S, Liao Y, D'Costa K, Kueh AJ, Hardy MP, Owczarek CM, Herold MJ, Spencer A, Shi W, Willis SN, Nutt SL, Corcoran LM.

Int J Mol Sci. 2018 Jul 24;19(8). pii: E2161. doi: 10.3390/ijms19082161.

20.

Cognitive Autopsy: A Transformative Group Approach to Mitigate Cognitive Bias.

Mehdi A, Foshee C, Green W, Spencer A.

J Grad Med Educ. 2018 Jun;10(3):345-347. doi: 10.4300/JGME-D-17-00884.1. No abstract available.

PMID:
29946399

Supplemental Content

Loading ...
Support Center